Researchers are reporting for the first time that nanoparticles — 1/5,000 the diameter of a human hair encapsulating an experimental anticancer agent — can kill human melanoma and drug-resistant breast cancer cells growing in laboratory cultures.
Researchers are reporting for the first time that nanoparticles — 1/5,000 the diameter of a human hair encapsulating an experimental anticancer agent — can kill human melanoma and drug-resistant breast cancer cells growing in laboratory cultures.